# Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis

> **NCT02526303** · NA · WITHDRAWN · sponsor: **Air Force Military Medical University, China**

## Conditions studied

- Liver Cirrhosis
- Portal Vein Thrombosis
- Anticoagulation

## Interventions

- **DRUG:** Nadroparin Calcium and Warfarin

## Key facts

- **NCT ID:** NCT02526303
- **Lead sponsor:** Air Force Military Medical University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2017-02
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02526303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02526303, "Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02526303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*